查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1251918

血漿蛋白質治療的全球市場 - 成長，未來預測，競爭分析(2023年～2031年)

Plasma Protein Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

全球血漿蛋白質治療的市場規模，2023年～2031預計以6.5％的年複合成長率成長。牽引市場的主要原因，是免疫球蛋白和白蛋白的莫大用途，適用於多種疾病，血漿蛋白質為基礎的新藥的研究開發的投資增加，免疫球蛋白在仿單標示外的使用增加。

本報告提供全球血漿蛋白質治療市場相關調查分析，市場動態，市場區隔分析，地區分析，企業簡介等資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 血漿蛋白質治療市場:競爭分析

  • 主要的血漿蛋白質治療市場供應商的市場定位
  • 血漿蛋白質治療市場供應商採用的策略
  • 主要的產業策略
  • 階層分析(2022年 vs. 2031年)

第4章 血漿蛋白質治療市場:常量分析和市場動態

  • 簡介
  • 全球血漿蛋白質治療的市場金額(2021年～2031年)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響的分析
  • See-Saw分析

第5章 血漿蛋白質治療市場:各產品(2021年～2031年)

  • 市場概要
  • 成長和收益的分析(2022年 vs. 2031年)
  • 市場區隔
    • 免疫球蛋白
    • 白蛋白
    • 凝血因子
    • Alpha-1蛋白酶抑制劑
    • 其他(C1-酯酶抑制劑、超免疫球蛋白)

第6章 血漿蛋白質治療市場:各用途(2021年～2031年)

  • 市場概要
  • 成長和收益的分析(2022年 vs. 2031年)
  • 市場區隔
    • 血友病
    • 原發性免疫缺陷症
    • 特發性血小板減少紫斑症
    • 續發性免疫力缺乏症
    • 其他(川崎病，遺傳性血管水腫，GBS，CIDP)

第7章 北美的血漿蛋白質治療市場(2021年～2031年)

  • 市場概要
  • 血漿蛋白質治療市場:各產品(2021年～2031年)
  • 血漿蛋白質治療市場:各用途(2021年～2031年)
  • 血漿蛋白質治療市場:各地區(2021年～2031年)
    • 北美

第8章 英國、歐洲聯盟的血漿蛋白質治療市場(2021年～2031年)

  • 市場概要
  • 血漿蛋白質治療市場:各產品(2021年～2031年)
  • 血漿蛋白質治療市場:各用途(2021年～2031年)
  • 血漿蛋白質治療市場:各地區(2021年～2031年)
    • 英國、歐洲聯盟

第9章 亞太地區的血漿蛋白質治療市場(2021年～2031年)

  • 市場概要
  • 血漿蛋白質治療市場:各產品(2021年～2031年)
  • 血漿蛋白質治療市場:各用途(2021年～2031年)
  • 血漿蛋白質治療市場:各地區(2021年～2031年)
    • 亞太地區

第10章 南美的血漿蛋白質治療市場(2021年～2031年)

  • 市場概要
  • 血漿蛋白質治療市場:各產品(2021年～2031年)
  • 血漿蛋白質治療市場:各用途(2021年～2031年)
  • 血漿蛋白質治療市場:各地區(2021年～2031年)
    • 南美

第11章 中東、非洲的血漿蛋白質治療市場(2021年～2031年)

  • 市場概要
  • 血漿蛋白質治療市場:各產品(2021年～2031年)
  • 血漿蛋白質治療市場:各用途(2021年～2031年)
  • 血漿蛋白質治療市場:各地區(2021年～2031年)
    • 中東、非洲

第12章 企業簡介

  • Baxter International
  • Biotests
  • CSL Behring
  • GRIFOLS, S.A
  • Kedrion
  • Octapharma USA, Inc.
  • Shire Plc.
  • China Biologics
  • 其他
Product Code: 138021-01-23

Plasma Protein Therapeutics Market Is Projected to Expand At A CAGR Of 6.5% Between 2023 And 2031. A variety of life-threatening & chronic disorders such as hematological diseases, immune deficiencies, genetic diseases, and neurological disorders among others are treated with plasma proteins. The different clinical responses of plasma proteins are due to their unique biochemical profile, and variances in production & processing technologies. Recent developments observed in the plasma protein therapeutics industry are satisfactory and groundbreaking, especially recently approved recombinant protein therapeutics which cater to several clinical indications such as autoimmune diseases, cancers, infectious diseases, and genetic disorders. These developments in plasma protein therapeutics technologies have allowed industry players to use the maximum potential of proteins in therapeutics by equivalently maintaining product safety and efficacy. The key factors driving this market are vast applications of immunoglobulins and albumin, catering to a wide range of diseases, rising investment in research and development of novel plasma protein-based drugs, and increasing off-label use of immunoglobulins.

The global regulatory framework is evolving daily with the incessant development of novel technologies in the biopharmaceutical industry. In the case of plasma protein therapeutics improved versions of current therapies are being introduced that are mainly attained through enhanced drug targeting and enhancement in functionality and potency. Thus, the plasma protein therapeutics market is expected to experience tremendous growth shortly.

North America was observed as the largest plasma protein therapeutics market due rising prevalence of chronic diseases, high acceptance & accessibility towards novel drug therapy, and mounting investments in R&D of plasma proteins therapeutics. Asia Pacific was observed as the fastest-growing plasma protein therapeutics market due to rising demand for novel therapeutics, developing healthcare infrastructure, and rising prevalence of cancer and autoimmune diseases.

New plasma-derived therapies entering the market are on the rise which is the major factor assisting the overall market growth. On the other hand, major market restraints include stringent regulatory policies, evolving reimbursement policies for developing the plasma protein therapeutics industry, and intricacy in manufacturing.

Key players identified for the plasma protein therapeutics market include:

Baxter International, Biotests, CSL Behring, GRIFOLS, S.A, Kedrion, Octapharma USA, Inc., Shire Plc., China Biologics, and Others.

Historical & Forecast Period

This study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Plasma Protein Therapeutics market is as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Plasma Protein Therapeutics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Immunoglobulins

Albumin

Coagulation Factors

Alpha-1 Proteinase Inhibitor

Others (C1-esterase Inhibitors & Hyperimmune Globulins)

Pipeline Analysis

Phase III Drugs Analysis, Forecast till 2026

Phase II & Phase I (Tabular Representation)

Application

Hemophilia

Primary Immunodeficiency Disorder

Idiopathic Thrombocytopenic Purpura

Secondary Immunodeficiency

Others (Kawasaki Disease, Hereditary Angioedema, GBS, and CIDP)

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Plasma Protein Therapeutics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Plasma Protein Therapeutics market?

Which is the largest regional market for Plasma Protein Therapeutics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Plasma Protein Therapeutics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Plasma Protein Therapeutics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Plasma Protein Therapeutics Market
  • 2.2. Global Plasma Protein Therapeutics Market, By Product, 2022 (US$ Million)
  • 2.3. Global Plasma Protein Therapeutics Market, By Application, 2022 (US$ Million)
  • 2.4. Global Plasma Protein Therapeutics Market, By Geography, 2022 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2022

3. Plasma Protein Therapeutics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Plasma Protein Therapeutics Market Vendors
  • 3.2. Strategies Adopted by Plasma Protein Therapeutics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Plasma Protein Therapeutics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Plasma Protein Therapeutics Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Immunoglobulins
    • 5.3.2. Albumin
    • 5.3.3. Coagulation Factors
    • 5.3.4. Alpha-1 Proteinase Inhibitor
    • 5.3.5. Others (C1-esterase Inhibitors & Hyperimmune Globulins)
    • 5.3.6. Pipeline Analysis
      • 5.3.6.1. Phase III Drugs Analysis, Forecast till 2026
      • 5.3.6.2. Phase II & Phase I (Tabular Representation)

6. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Hemophilia
    • 6.3.2. Primary Immunodeficiency Disorder
    • 6.3.3. Idiopathic Thrombocytopenic Purpura
    • 6.3.4. Secondary Immunodeficiency
    • 6.3.5. Others (Kawasaki Disease, Hereditary Angioedema, GBS, and CIDP)

7. North America Plasma Protein Therapeutics Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
  • 7.3. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
  • 7.4.Plasma Protein Therapeutics Market: By Region, 2021-2031, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 7.4.1.1.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 7.4.1.2.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 7.4.1.3.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)

8. UK and European Union Plasma Protein Therapeutics Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
  • 8.3. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
  • 8.4.Plasma Protein Therapeutics Market: By Region, 2021-2031, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.1.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.2.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.3.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.4.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.5.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.6.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)

9. Asia Pacific Plasma Protein Therapeutics Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
  • 9.3. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
  • 9.4.Plasma Protein Therapeutics Market: By Region, 2021-2031, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.1.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.2.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.3.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.4.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.5.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.6.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)

10. Latin America Plasma Protein Therapeutics Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
  • 10.3. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
  • 10.4.Plasma Protein Therapeutics Market: By Region, 2021-2031, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 10.4.1.1.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 10.4.1.2.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 10.4.1.3.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)

11. Middle East and Africa Plasma Protein Therapeutics Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
  • 11.3. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
  • 11.4.Plasma Protein Therapeutics Market: By Region, 2021-2031, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 11.4.1.1.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 11.4.1.2.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
        • 11.4.1.3.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)

12. Company Profile

  • 12.1. Baxter International
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Biotests
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. CSL Behring
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. GRIFOLS, S.A
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Kedrion
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Octapharma USA, Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Shire Plc.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. China Biologics
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Others
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 2 Global Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 3 Global Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 4 North America Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 5 North America Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 6 North America Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 7 U.S. Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 8 U.S. Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 9 U.S. Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 10 Canada Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 11 Canada Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 12 Canada Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 19 UK Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 20 UK Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 21 UK Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 22 Germany Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 23 Germany Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 24 Germany Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 25 Spain Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 26 Spain Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 27 Spain Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 28 Italy Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 29 Italy Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 30 Italy Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 31 France Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 32 France Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 33 France Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 37 Asia Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 38 Asia Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 39 Asia Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 40 China Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 41 China Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 42 China Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 43 Japan Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 44 Japan Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 45 Japan Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 46 India Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 47 India Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 48 India Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 49 Australia Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 50 Australia Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 51 Australia Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 52 South Korea Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 53 South Korea Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 54 South Korea Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 55 Latin America Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 56 Latin America Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 57 Latin America Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 58 Brazil Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 59 Brazil Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 60 Brazil Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 61 Mexico Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 62 Mexico Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 63 Mexico Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 70 GCC Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 71 GCC Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 72 GCC Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 73 Africa Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 74 Africa Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 75 Africa Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Plasma Protein Therapeutics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Plasma Protein Therapeutics Market: Quality Assurance
  • FIG. 5 Global Plasma Protein Therapeutics Market, By Product, 2022
  • FIG. 6 Global Plasma Protein Therapeutics Market, By Application, 2022
  • FIG. 7 Global Plasma Protein Therapeutics Market, By Geography, 2022
  • FIG. 8 Market Geographical Opportunity Matrix - Global Plasma Protein Therapeutics Market, 2022
  • FIG. 9 Market Positioning of Key Plasma Protein Therapeutics Market Players, 2022
  • FIG. 10 Global Plasma Protein Therapeutics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 11 Global Plasma Protein Therapeutics Market, By Product, 2022 Vs 2031, %
  • FIG. 12 Global Plasma Protein Therapeutics Market, By Application, 2022 Vs 2031, %
  • FIG. 13 U.S. Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 14 Canada Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 15 Rest of North America Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 16 UK Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 17 Germany Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 18 Spain Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 19 Italy Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 20 France Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 21 Rest of Europe Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 22 China Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 23 Japan Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 24 India Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 25 Australia Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 26 South Korea Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 27 Rest of Asia Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 28 Brazil Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 29 Mexico Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 30 Rest of Latin America Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 31 GCC Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 32 Africa Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 33 Rest of Middle East and Africa Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031